Perkinelmer News
Most Popular Perkinelmer Story
Genzyme dickers over sales deals as Sanofi dangles
When Sanofi CEO Chris Viehbacher outlined his desire to buy Genzyme for $18.5 billion, he cited the biotech's diagnostics business as one particular area that made an alliance attractive. But as Read more...
Latest Headlines
- September 2, 2010
- February 19, 2008
- October 16, 2007
- December 20, 2006
- December 13, 2006
- November 30, 2006
- June 7, 2006
- June 4, 2006
- March 9, 2006
- January 24, 2006
- January 17, 2006
- December 20, 2005
- November 8, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
